Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Vyant Bio to Neutral

HC Wainwright & Co. Downgrades Vyant Bio to Neutral

HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.

byBenzinga Newsdesk

February 3, 2023

1 minute read

HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.

Analyst Ratings

11 Analysts Have This to Say About Norfolk Southern

By Benzinga Insights

April 4, 8:05 AM

Within the last quarter, Norfolk Southern (NYSE:NSC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

NSC

Analyst Ratings

The Analyst Landscape: 20 Takes On Ecolab

By Benzinga Insights

May 1, 12:00 PM

20 analysts have shared their evaluations of Ecolab (NYSE:ECL) during the recent three months, expressing a mix of…

ECL

Analyst Ratings

Analyst Expectations For Warrior Met Coal’s Future

By Benzinga Insights

May 2, 1:00 PM

Analysts’ ratings for Warrior Met Coal (NYSE:HCC) over the last quarter vary from bullish to bearish, as provided…

HCC

‘Buy China, Sell AI’ Is The Ultimate Contrarian Trade By This Top Wall Street Analyst: Find Out Why

By Piero Cingari

June 2, 4:09 PM

As investors continue to flock to technology firms on the back of the AI boom, contrarian investors on Wall Street are contemplating the next move to profit on setbacks from the current market euphoria.

AAPL

HC Wainwright & Co. Downgrades Vyant Bio to Neutral

Related Posts

11 Analysts Have This to Say About Norfolk Southern

The Analyst Landscape: 20 Takes On Ecolab

Analyst Expectations For Warrior Met Coal’s Future

‘Buy China, Sell AI’ Is The Ultimate Contrarian Trade By This Top Wall Street Analyst: Find Out Why